|
Understand glioma biology
|
ZIA BC 011760
|
$289,615
|
$289,615
|
Yang, Chun Zhang
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$474,811
|
$94,962
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tumor heterogeneity in breast cancer brain metastasis after brain radiation
|
ZIA BC 011330
|
$38,987
|
$19,494
|
Smart, DeeDee
|
CCR (NCI)
|
|
Transcriptional regulation of inflammatory and autoimmune responses
|
ZIA BC 011765
|
$337,305
|
$337,305
|
Lazarevic, Vanja
|
CCR (NCI)
|
|
TNF Signaling, Cell Death and Cancer
|
ZIA SC 010376
|
$868,062
|
$607,643
|
Liu, Zheng-Gang
|
CCR (NCI)
|
|
Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
|
ZIA BC 010801
|
$719,531
|
$539,648
|
Widemann, Brigitte
|
CCR (NCI)
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$640,845
|
$512,676
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression
|
ZIA BC 010015
|
$331,011
|
$248,258
|
Wang, Ji Ming
|
CCR (NCI)
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S1
|
$204,369
|
$2,044
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S2
|
$57,797
|
$578
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S3
|
$79,482
|
$795
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-23
|
$4,865,652
|
$48,657
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The mechanism and function of cell competition in tumors
|
5K22CA190440-03
|
$175,424
|
$175,424
|
LI, WEI
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
The Hippo Pathway in Human Gliomas
|
ZIA BC 011649
|
$158,514
|
$158,514
|
Stommel, Jayne
|
CCR (NCI)
|
|
The effect of therapeutics on mutated IDH1 cell lines and mice tumor models
|
ZIA BC 011707
|
$172,138
|
$172,138
|
Larion, Mioara
|
CCR (NCI)
|
|
TEDDI-R in PCNSL
|
ZIA BC 011654
|
$146,012
|
$138,712
|
Wilson, Wyndham
|
CCR (NCI)
|
|
Targeting the Kinome in Neurofibromatosis type 1
|
5R01CA142928-08
|
$434,625
|
$434,625
|
CHERNOFF, JONATHAN
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Targeted and untargeted metabolomics in IDH1 mutated xenografts in mice
|
ZIA BC 011708
|
$172,138
|
$172,138
|
Larion, Mioara
|
CCR (NCI)
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$924,476
|
$92,448
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
|
ZIA BC 011109
|
$42,641
|
$2,985
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
Study of Anti-Survival signals in NF1
|
5R01CA153354-06
|
$225,443
|
$225,443
|
CHEN, CHANGYAN
|
NORTHEASTERN UNIVERSITY
|
|
Study of AAA proteins by X-ray protein crystallography
|
ZIA BC 010600
|
$145,734
|
$145,734
|
Xia, Di
|
CCR (NCI)
|
|
Studies of amplification in rhabdomyosarcoma
|
ZIA BC 011378
|
$218,891
|
$21,889
|
Barr, Frederic
|
CCR (NCI)
|
|
Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells
|
ZIA BC 011777
|
$24,641
|
$5,175
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$427,953
|
$149,783
|
Daar, Ira
|
CCR (NCI)
|
|
Schwann Cell Reprogramming and Cancer Perineural Invasion
|
1R01CA219534-01
|
$652,045
|
$652,045
|
WONG, RICHARD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIA BC 010391
|
$512,529
|
$153,759
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis
|
ZIA BC 011431
|
$337,305
|
$337,305
|
Lazarevic, Vanja
|
CCR (NCI)
|
|
Role of Shh in developmental patterning and growth of digit skeleton
|
ZIA BC 011118
|
$305,052
|
$30,505
|
Mackem, Susan
|
CCR (NCI)
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIA BC 010390
|
$525,343
|
$525,343
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of Neurogenic Inflammation in Pancreatic Cancer
|
5R01CA177857-05
|
$418,087
|
$418,087
|
DAVIS, BRIAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Role of Formylpeptide Receptors in Host Defense
|
ZIA BC 010725
|
$331,011
|
$165,505
|
Wang, Ji Ming
|
CCR (NCI)
|
|
Role of Brachyury in regulating notochord development and neoplasia
|
ZIA BC 011121
|
$101,684
|
$40,674
|
Mackem, Susan
|
CCR (NCI)
|
|
Relationship between DNA damage detection and signaling
|
ZIA BC 010959
|
$1,182,201
|
$591,100
|
Nussenzweig, Andre
|
CCR (NCI)
|
|
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
|
ZIA BC 010788
|
$665,693
|
$532,555
|
Thiele, Carol
|
CCR (NCI)
|
|
Regulation of Ciliogenesis and Ciliary-related signaling
|
ZIA BC 011398
|
$997,455
|
$99,746
|
Westlake, Christopher
|
CCR (NCI)
|
|
Regulation and functional effects of localized RNAs
|
ZIA BC 011501
|
$649,134
|
$64,913
|
Mili, Stavroula
|
CCR (NCI)
|
|
Rare Central Nervous System Cancers Initiative
|
ZIA BC 011643
|
$271,818
|
$271,818
|
Gilbert, Mark
|
CCR (NCI)
|
|
Radiation-induced translational control of gene expression
|
ZIA BC 011373
|
$537,786
|
$484,007
|
Tofilon, Philip
|
CCR (NCI)
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$4,983,045
|
$797,287
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Preclinical evaluation of novel therapeutics for CNS tumor therapy
|
ZIA BC 011340
|
$402,060
|
$361,854
|
Warren, Katherine
|
CCR (NCI)
|
|
Pre-clinical Translational Research Facility
|
ZIC BC 011641
|
$1,242,597
|
$1,242,597
|
Gilbert, Mark
|
CCR (NCI)
|
|
Postmortem Pathology
|
ZIC BC 010685
|
$699,211
|
$69,921
|
Kleiner, David
|
CCR (NCI)
|
|
Physiological and pathological functions of E3 ubiquitin ligases Smurfs
|
ZIA BC 011168
|
$538,344
|
$161,503
|
Zhang, Ying
|
CCR (NCI)
|
|
Phospholipid and Sphingolipid Signaling in Drosophila
|
ZIA BC 010331
|
$147,835
|
$147,835
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas
|
ZIA BC 010580
|
$9,573
|
$9,573
|
Warren, Katherine
|
CCR (NCI)
|
|
Phase II trial of mTORC1/mTORC2 inhibitor AZD2014 for sporadic meningioma
|
5R01CA201130-02
|
$401,017
|
$401,017
|
RAMESH, VIJAYA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
PHASE II OPTION FOR SBIR CONTRACT - FAST TRACK TRANSITION. PLATFORM FOR NEUROCOGNITIVE EVALUATION AND MONITORING. JUNE 19, 2016 - DECEMBER 18, 2019. CAN #8478358.
|
261201600024C
|
$1,499,991
|
$1,499,991
|
UNKNOWN, UNKNOWN
|
VIRIDIAN TECHNOLOGIES, INC.
|
|
Phase I Trial of Radiation and Lenalidomide in Pediatric Malignant Glioma
|
ZIA BC 011298
|
$47,864
|
$47,864
|
Warren, Katherine
|
CCR (NCI)
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 011516
|
$3,583,320
|
$1,433,328
|
Glod, John
|
CCR (NCI)
|
Total relevant funding to Nervous System for this search: $33,640,923
|